HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Shigehiro Ohdo Selected Research

Chronobiology Disorders (Circadian Rhythm Disorder)

11/2015Mitomycin C modulates the circadian oscillation of clock gene period 2 expression through attenuating the glucocorticoid signaling in mouse fibroblasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Shigehiro Ohdo Research Topics

Disease

16Neoplasms (Cancer)
01/2014 - 01/2003
3Neuralgia (Stump Neuralgia)
07/2015 - 01/2010
3Hyperalgesia
07/2015 - 01/2010
3Breast Neoplasms (Breast Cancer)
05/2012 - 01/2004
3Neoplasm Metastasis (Metastasis)
01/2012 - 01/2003
3Heart Failure
07/2010 - 07/2002
3Asthma (Bronchial Asthma)
07/2010 - 01/2003
3Anoxia (Hypoxia)
01/2010 - 11/2003
2Colonic Neoplasms (Colon Cancer)
12/2013 - 08/2010
2Necrosis
01/2013 - 06/2010
2Hypersensitivity (Allergy)
04/2011 - 01/2010
2Arthritis (Polyarthritis)
07/2010 - 01/2003
2Myocardial Infarction
07/2010 - 01/2003
2Inflammation
07/2010 - 08/2009
2Stroke (Strokes)
07/2010 - 01/2003
2Rhinitis
07/2010 - 01/2003
2Peptic Ulcer (Peptic Ulcers)
07/2010 - 01/2003
2Type 2 Diabetes Mellitus (MODY)
11/2009 - 02/2008
2Cardiovascular Diseases (Cardiovascular Disease)
08/2009 - 02/2008
2Leukemia
11/2008 - 12/2005
2Leukopenia
06/2008 - 09/2005
2Colorectal Neoplasms (Colorectal Cancer)
02/2007 - 01/2003
2Stomatitis
02/2007 - 01/2003
2Ocular Hypertension (Glaucoma, Suspect)
01/2006 - 01/2006
2Open-Angle Glaucoma (Glaucoma, Open Angle)
01/2006 - 01/2006
2Atherosclerosis
08/2003 - 03/2003
2Diabetes Mellitus
08/2003 - 09/2002
2Body Weight (Weight, Body)
01/2003 - 01/2002
1Glaucoma
11/2015
1Chronobiology Disorders (Circadian Rhythm Disorder)
11/2015
1Peripheral Nervous System Diseases (PNS Diseases)
07/2015
1Diabetic Neuropathies (Diabetic Neuropathy)
07/2015
1Renal Cell Carcinoma (Grawitz Tumor)
01/2014
1Parkinson Disease (Parkinson's Disease)
06/2013
1Neuroblastoma
06/2013
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2013
1Lung Neoplasms (Lung Cancer)
05/2013
1Rheumatoid Arthritis
04/2013
1Experimental Arthritis
04/2013
1Osteosarcoma (Osteogenic Sarcoma)
01/2013
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2013
1Fibrosis (Cirrhosis)
10/2012
1Pain (Aches)
04/2011
1Hyperlipidemias (Hyperlipidemia)
10/2010
1Budd-Chiari Syndrome (Budd Chiari Syndrome)
06/2010

Drug/Important Bio-Agent (IBA)

9Messenger RNA (mRNA)IBA
01/2014 - 11/2003
4DNA (Deoxyribonucleic Acid)IBA
08/2010 - 12/2005
3Phosphotransferases (Kinase)IBA
05/2013 - 11/2006
3oxaliplatin (Eloxatin)FDA LinkGeneric
08/2010 - 01/2003
3Lipoproteins (Lipoprotein)IBA
11/2009 - 09/2002
3We 201IBA
11/2009 - 03/2003
3irinotecan (Camptosar)FDA LinkGeneric
02/2009 - 01/2003
3docetaxel (Taxotere)FDA Link
06/2008 - 01/2004
3Doxorubicin (Adriamycin)FDA LinkGeneric
06/2008 - 01/2004
3Fluorouracil (Carac)FDA LinkGeneric
04/2008 - 01/2003
21-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
11/2009 - 02/2008
2Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
11/2009 - 02/2008
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
08/2008 - 11/2006
2Leucovorin (Folinic Acid)FDA Link
02/2007 - 01/2003
2K 351 (nipradilol)IBA
01/2006 - 01/2006
1Mitomycin (Mitomycin-C)FDA LinkGeneric
11/2015
1pregabalin (Lyrica)FDA Link
07/2015
1Streptozocin (Streptozotocin)FDA Link
07/2015
1UbiquitinIBA
01/2014
1TOR Serine-Threonine KinasesIBA
01/2014
1everolimusFDA Link
01/2014
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
06/2013
1Dopamine (Intropin)FDA LinkGeneric
06/2013
1((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA
05/2013
1erlotinib (CP 358,774)FDA Link
05/2013
1gefitinib (Iressa)FDA Link
05/2013
1nutlin 3IBA
04/2013
1Activating Transcription Factor 4IBA
04/2013
1HLA-G antigen (HLA G)IBA
04/2013
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2013
1ozagrelIBA
01/2013
1Alanine Transaminase (SGPT)IBA
01/2013
1Transcription Factor CHOPIBA
01/2013
1Glutathione (Reduced Glutathione)IBA
01/2013
1Thromboxane B2IBA
01/2013
1G-Protein-Coupled Receptor Kinase 5IBA
10/2012
1GTP-Binding Proteins (G-Protein)IBA
10/2012
1Metoprolol (Lopressor)FDA LinkGeneric
10/2012
1Adenosine Triphosphate (ATP)IBA
05/2012
1Transcription Factors (Transcription Factor)IBA
01/2012
1tocilizumabFDA Link
01/2012
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2012
1flavopiridolIBA
04/2011
1Plasminogen Activator Inhibitor 1IBA
10/2010
1Plasminogen Activators (Plasminogen Activator)IBA
10/2010
1ChromatinIBA
10/2010
1Transferrin (beta 2 Transferrin)IBA
08/2010
1PlatinumIBA
08/2010
1Transferrin Receptors (Transferrin Receptor)IBA
08/2010
1Liposomes (Liposome)IBA
08/2010
1Dacarbazine (DIC)FDA LinkGeneric
06/2010

Therapy/Procedure

4Chronotherapy
07/2010 - 01/2003
2Drug Therapy (Chemotherapy)
07/2015 - 01/2010
1Trabeculectomy (Trabeculoplasty)
11/2015
1Oral Administration
07/2015